Concord Biotech Limited (BOM:543960)
India · Delayed Price · Currency is INR 1,420.30
+87.10 (6.53%)
At close: Jul 31, 2026
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 148.64 billion as of July 31, 2026. Its market cap has decreased by -22.11% in one year.
Market Cap
148.64B
Enterprise Value
144.32B
Revenue
11.08B
Ranking
n/a
PE Ratio
53.98
Stock Price
1,420.30
ChartMarket Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 148.64B, an increase of 50.70%. That is a compound annual growth rate of 14.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 148.64B | 5.59% |
| Dec 31, 2025 | 140.77B | -39.13% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
| Aug 18, 2023 | 98.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 245.64B |
| Granules India | 204.20B |
| AstraZeneca Pharma India | 202.59B |
| Caplin Point Laboratories | 191.15B |
| Jubilant Pharmova | 148.07B |
| CORONA Remedies | 128.36B |
| Viyash Scientific | 110.01B |